Cancer Database Query Results

Scientific Papers found: Click to Expand⟱
7303- GoldNP,  PDT,    Gold nanoshell-localized photothermal ablation of prostate tumors in a clinical pilot device study
- Trial, Pca, NA
eff↑, PSA↓,
7320- Gos,    AT-101 Enhances the Antitumor Activity of Lenalidomide in Patients with Multiple Myeloma
- Trial, Melanoma, NA
Bcl-2↓, Mcl-1↓, Apoptosis↑, Synergy↑, toxicity↝, ORR↑,
7317- Gos,    A phase II study of AT-101 (gossypol) in chemotherapy-sensitive recurrent extensive stage small cell lung cancer (ES-SCLC)
- Trial, Lung, NA
Bcl-2↓, Bcl-xL↓, Mcl-1↓, NOXA↑, PUMA↑, Dose↝, eff↓,
7316- Gos,  PacT,  carbop,  Chemo,    A phase I study of AT-101, a BH3 mimetic, in combination with paclitaxel and carboplatin in solid tumors
- Trial, Var, NA
Bcl-2↓, Bcl-xL↓, Mcl-1↓, Dose↝, toxicity↝,
7328- GSE,    Effects of grape seed extract beverage on blood pressure and metabolic indices in individuals with pre-hypertension: a randomised, double-blinded, two-arm, parallel, placebo-controlled trial
- Trial, Nor, NA
*Dose↝, *BP↓, *other↝, *eff↑,
7324- GSE,    A Pilot Study of a Grape Seed Procyanidin Extract for Lung Cancer Chemoprevention
- Trial, Lung, NA
BioAv↑, toxicity↝, Ki-67↓, miR-106b↓, chemoPv↑, Dose↝, miR-19b↓, PTEN↑, IGF-2R↑, p‑Akt↓, PGE2↓, PGI2↓, COX2/PTGS2↓, Apoptosis↑, TumCP↓, Inflam↓, cardioP↑,
7329- GSE,    Grape Seed Extract Positively Modulates Blood Pressure and Perceived Stress: A Randomized, Double-Blind, Placebo-Controlled Study in Healthy Volunteers
- Trial, Nor, NA
*Dose↝, *BP↓,
7134- GSL,    Phase I study of oral spirogermanium
- Trial, Var, NA
*Dose↝, toxicity↝, Bil∅, toxicity↝, Dose↓,
7481- H2,  Rad,    Clinical Efficacy of Hydrogen Therapy on Acute Radiation Enteritis and Inflammatory Response in Patients with Cervical Cancer Undergoing Concurrent Chemoradiation Therapy
- Trial, Var, NA
Dose↝, CRP↓, NLR↓, IL6↓, AntiTum∅, *toxicity↓, Inflam↓, radioP↑, *IBI↑, *ROS↓,
7486- H2,    Effects of hydrogen-rich water on blood uric acid in patients with hyperuricemia: A randomized placebo-controlled trial
- Trial, Nor, NA
*eff↑, *uricA↓, *toxicity↓, *antiOx↑, *Inflam↓, *Dose↝, *Dose↝, *Dose↝, *toxicity↓, *Dose↓, *ROS↓,
3768- H2,    Effects of Hydrogen Gas Inhalation on Community-Dwelling Adults of Various Ages: A Single-Arm, Open-Label, Prospective Clinical Trial
- Trial, AD, NA
*ROS↓, *NO↓, *BACE/β-secretase↓, *BDNF↑, *VEGF↑, *p‑tau↓, *MCP1/CCL2↓, *IL6↓, *cognitive↑, *toxicity∅,
2524- H2,    Protective effect of hydrogen-rich water on liver function of colorectal cancer patients treated with mFOLFOX6 chemotherapy
- Trial, Var, NA
hepatoP↑, *ALAT↓, *AST↓, Dose↝, Dose↝,
2505- H2,    Hydrogen gas restores exhausted CD8+ T cells in patients with advanced colorectal cancer to improve prognosis
- Trial, CRC, NA
PGC-1α↑, Dose↝, CD8+↑, OS↑,
2504- H2,    Hydrogen gas activates coenzyme Q10 to restore exhausted CD8+ T cells, especially PD-1+Tim3+terminal CD8+ T cells, leading to better nivolumab outcomes in patients with lung cancer
- Trial, Lung, NA
CD8+↑, OS↑, eff↝, CoQ10↑, PDT+↓, PGC-1α↑, Dose↝, *toxicity∅,
1438- HCQ,  Chemo,    Adding Chloroquine to Conventional Treatment for Glioblastoma Multiforme
- Trial, GBM, NA
OS↑, *toxicity∅,
7505- HCQ,  GEM,  PacT,    A Randomized Phase II Preoperative Study of Autophagy Inhibition with High-Dose Hydroxychloroquine and Gemcitabine/Nab-Paclitaxel in Pancreatic Cancer Patients
- Trial, PC, NA
eff↑, TumAuto↓, Imm↑, CA19-9↓, OS↑,
7349- HibSad,    Pharmacokinetics of anthocyanidin-3-glycosides following consumption of Hibiscus sabdariffa L. extract
- Trial, Nor, NA
*Dose↝, *Half-Life↓, *Half-Life↝, *BioAv↓, *antiOx↑, *BioAv↓,
7346- Hne,    Subcutaneous application of Helleborus niger 12x in older patients with dementia-a retrospective cohort study
- Trial, AD, NA
*cognitive↑,
7373- HOO,    Effects of topical ozonated olive oil on lipid profile, quality of life, wound healing and glycemic control in patients with diabetic foot ulcers: a randomized controlled trial
- Trial, Diabetic, NA
*Wound Healing↑, *QoL↑,
7650- HPT,    Hyperthermia and radiation therapy for locally advanced or recurrent breast cancer
- Trial, BC, NA
OS↑, LC↑,
7624- HPT,  Chemo,    A multicentre randomised clinical trial of chemoradiotherapy plus hyperthermia versus chemoradiotherapy alone in patients with locally advanced cervical cancer
- Trial, Cerv, NA
OS↑, CR↑, *toxicity↓,
7618- HPT,    ESHO 2-85. Hyperthermia as an adjuvant to radiation therapy in the treatment of advanced neck nodes: A randomized multicenter study by the European Society for Hyperthermic Oncology
- Trial, HNSCC, NA
ORR↑, NA↑, NA↑, BioAv↝, Dose↝, Dose↝,
7621- HPT,  Rad,    Clinical effectiveness of combined whole body hyperthermia and external beam radiation therapy (EBRT) versus EBRT alone in patients with painful bony metastases: A phase III clinical trial study
- Trial, Pca, NA - Trial, BC, NA
Pain↓, Dose↝, CR↑,
7597- HPT,    Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group
- Trial, Var, NA
ORR↑, OS↑,
7577- HPT,  Rad,    Randomized trial of hyperthermia and radiation for superficial tumors
- Trial, Var, NA
RadioS↑, eff↑, Dose↝,
7627- HPT,  Rad,    Local control rate after the combination of re-irradiation and hyperthermia for irresectable recurrent breast cancer: Results in 248 patients
- Trial, BC, NA
CR↑, OS↑, *toxicity↝, RadioS↑,
7477- HRT,    Cognitive effects of estradiol after menopause: A randomized trial of the timing hypothesis
- Trial, Nor, NA
*Dose↝, *memory∅, *cognitive∅,
7543- HT,    Hydroxytyrosol supplementation increases vitamin C levels in vivo. A human volunteer trial
- Trial, Nor, NA
VitC↑,
7524- HT,    The Pharmaceutical Formulation Plays a Pivotal Role in Hydroxytyrosol Pharmacokinetics
- Trial, Nor, NA
*Dose↝, *BioAv↝, *Half-Life↝, *toxicity↓, *BioAv↝, *BioAv↝,
7526- HT,    Hydroxytyrosol in functional hydroxytyrosol-enriched biscuits is highly bioavailable and decreases oxidised low density lipoprotein levels in humans
- Trial, Nor, NA
*Half-Life↝, *BioAv↑, *Dose↝, *BioAv↝,
7536- HT,    Effects of Desert Olive Tree Pearls Containing High Hydroxytyrosol Concentrations on the Cognitive Functions of Middle-Aged and Older Adults
- Trial, AD, NA
*Dose↑, *motorD↑, *cognitive↑, *Dose↝,
7541- HT,    Hydroxytyrosol Supplementation Modifies Plasma Levels of Tissue Inhibitor of Metallopeptidase 1 in Women with Breast Cancer
- Trial, BC, NA
Dose↝, MMP9↓, TIMP1↓,
4635- HT,    Hydroxytyrosol, a Component of Olive Oil for Breast Cancer Prevention in Women at High Risk of Cancer
- Trial, BC, NA
*Wnt↓, *NOTCH↓, *ROS↓, TumCP↓, CSCs↓,
7479- Hup,    A phase II trial of huperzine A in mild to moderate Alzheimer disease
- Trial, AD, NA
*Dose↝, *cognitive↑, *eff∅, *AChE↓,
7480- Hup,    Pharmacokinetics of huperzine A following oral administration to human volunteers
- Trial, AD, NA
*Dose↝, *BioAv↝, *Half-Life↝,
7602- I3C,    Dose-ranging study of indole-3-carbinol for breast cancer prevention
- Trial, BC, NA
toxicity↓, Dose↝, 2/16-OHE1↑, chemoPv↑,
7611- I3C,    Long-term responses of women to indole-3-carbinol or a high fiber diet
- Trial, Nor, NA
*Dose↝, *2/16-OHE1↑,
7580- I3C,    Single-dose and multiple-dose administration of indole-3-carbinol to women: pharmacokinetics based on 3,3'-diindolylmethane
- Trial, Var, NA
Dose↝, BioAv↝, Dose↝,
7581- I3C,    A phase I study of indole-3-carbinol in women: tolerability and effects
- Trial, Nor, NA
CYP1A2↑, Dose↝,
7578- IMA,    Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia
- Trial, CML, NA
OS↑, toxicity↓, BCR-ABL↓,
7579- IMA,    One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial
- Trial, GC, NA
RFS↑, OS↑,
7616- Ins,    A phase I study of myo-inositol for lung cancer chemoprevention
- Trial, Nor, NA
*Dose↝, *toxicity↝, *BP↓,
7615- Ins,    A Randomized Phase IIb Trial of myo-Inositol in Smokers with Bronchial Dysplasia
- Trial, Nor, NA
*Dose↝, *IL6↓, *PI3K↓,
7643- Ins,  IP6,    Efficacy of IP6 + inositol in the treatment of breast cancer patients receiving chemotherapy: prospective, randomized, pilot clinical stud
- Trial, BC, NA
RBC↑, QoL↑, Synergy↑, Imm↑, ChemoSen↑, chemoP↑, Dose↝,
7634- Ins,    Risk of reduced intestinal absorption of myo-inositol caused by D-chiro-inositol or by glucose transporter inhibitors
- Trial, Nor, NA
*BioAv↓,
7633- Ins,    Myo-inositol in a new pharmaceutical form: a step forward to a broader clinical use
- Trial, Nor, NA
*BioAv↑, *toxicity↓,
7672- iod,    Adjuvant Effect of Molecular Iodine in Conventional Chemotherapy for Breast Cancer. Randomized Pilot Study
- Trial, BC, NA
Dose↝, OS↑, TumCI↓, Apoptosis↑, EstroRS/ERS↑, Synergy↑, *cardioP↑, *antiOx↑, *Inflam↓,
7673- iod,  Chemo,    Adjuvant Effect of Molecular Iodine in Conventional Chemotherapy for Breast Cancer. Randomized Pilot Study
- Trial, BC, NA
Dose↝, *chemoP↑,
7684- iod,    Molecular iodine impairs chemotherapy resistance and adverse effects in breast cancer treatments
- Trial, BC, NA
Dose↝, OS↑, antiNeop↑, eff↑,
7661- IP,    Enhancement of carbohydrate metabolism by probiotic and prebiotic intake promotes short-chain fatty acid production in the gut microbiome: a randomized, double-blind, placebo-controlled crossover trial
- Trial, Nor, NA
*PA↑, *Buty↑, *GutMicro↑, *SCFAs↑,

Showing Research Papers: 251 to 300 of 542
Prev Page 6 of 11 Next

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 542

Pathway results for Effect on Cancer / Diseased Cells:


NA, unassigned(tgid=0) ⓘ

NA↑, 2,  

Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↑, 2,   Bil∅, 1,   Copper↓, 2,   CoQ10↑, 1,   GSH↓, 1,   MDA↓, 1,   ROS↓, 3,   ROS↑, 5,   ROS↝, 2,   SOD↑, 1,   TrxR↓, 1,   VitC↑, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

selm↑, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

BCR-ABL↓, 1,   Insulin↓, 2,   PGC-1α↑, 2,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

5LO↓, 1,   ALAT↓, 1,   FAO↑, 1,   lactateProd↓, 1,   PDK1 / PDPK1↓, 2,  

Cell Death(tgid=5) ⓘ

Apoptosis↑, 8,   Bcl-2↓, 3,   Bcl-xL↓, 2,   Cyt‑c↝, 1,   IAP1↓, 1,   Mcl-1↓, 3,   NOXA↑, 1,   Perforin↑, 1,   PUMA↑, 1,   survivin↓, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

ADCY4↑, 1,   p‑Akt↓, 1,   EGFR↓, 3,   IGF-2R↑, 1,   IGFR↓, 1,   PI3K↓, 1,   PTEN↑, 2,  

Transcription & Epigenetics(tgid=7) ⓘ

HDAC↓, 4,   miR-106b↓, 1,   miR-19b↓, 1,   miR-29b↑, 1,   miR-30a-5p↑, 1,   Myc↓, 1,   other?, 1,   other↓, 4,   other↑, 6,   other↝, 24,   other∅, 3,   SD↑, 5,   SD↝, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

NEU1↑, 1,   TumAuto↓, 1,   TumAuto↑, 1,  

DNA Damage & Repair(tgid=10) ⓘ

8-oxo-dG↓, 1,   NKX3.1↓, 1,   P53↑, 1,   RAD51↓, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

cellSen?, 1,   cycD1/CCND1↓, 2,   Ki-67↓, 6,   P21↑, 3,   TumCCA↑, 5,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

ALDH↓, 1,   CSCs↓, 2,   HH↓, 3,   HH∅, 1,   IGF-1↓, 7,   IGF-1↑, 1,   IGFBP1↑, 2,   IGFBP3↓, 1,   IGFBP3↑, 1,   JAG1↑, 1,   Ki-67↓, 6,   NOTCH3↑, 1,   Smo↓, 1,   TumCG↓, 9,   TumCP↓, 11,   Wnt↓, 1,  

Migration(tgid=13) ⓘ

AntiAg↝, 1,   AntiAg∅, 1,   Ca+2↓, 1,   Ca+2↑, 1,   GLI3↓, 1,   MMP2↓, 1,   MMP9↓, 2,   MMP9:TIMP1↑, 1,   Slug↓, 2,   p‑SMAD2↓, 1,   p‑SMAD3↓, 1,   Snail↓, 1,   TGF-β↓, 1,   TIMP1↓, 1,   TumCA↓, 3,   TumCI↓, 3,   TumCMig↓, 3,   TumMeta↓, 2,   TumMeta↑, 1,   TumMeta∅, 1,   Twist↓, 1,   Vim↓, 1,   β-catenin/ZEB1↓, 2,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 9,   angioG∅, 1,   E-sel↓, 1,   Endoglin↓, 1,   Hif1a↓, 2,   PGI2↓, 1,   VEGF↓, 4,   VEGFR2/KDR/Flk1↑, 1,  

Barriers & Transport(tgid=15) ⓘ

BBB↑, 1,   IBI↑, 1,   MPT↑, 1,   TRPV1↑, 1,   ZO-1↓, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

ALC↓, 1,   ANXA1↓, 1,   CD14↓, 1,   CD25+↓, 1,   CD4+↓, 1,   CD4+↑, 3,   CD8+↑, 5,   COX2/PTGS2↓, 4,   COX2/PTGS2∅, 1,   Eos↑, 1,   FoxP3+↓, 1,   Gal-3?, 1,   Gal-3↓, 1,   GM-CSF↓, 1,   IFN-γ↑, 2,   IL10↓, 1,   IL10↑, 1,   IL12↓, 1,   IL18↑, 1,   IL1β↓, 2,   IL1β∅, 1,   IL2↑, 1,   IL22↓, 1,   IL6↓, 4,   Imm↑, 12,   Imm⇅, 1,   Imm↝, 1,   INF-γ↝, 1,   Inflam↓, 9,   LIF↑, 1,   MCP1/CCL2↓, 1,   Neut↓, 1,   Neut↑, 2,   NF-kB↓, 4,   NK cell↑, 4,   PDT+↓, 1,   PGE2↓, 2,   PSA↓, 16,   T-Cell↑, 1,   TNF-α↓, 2,   TNF-α↑, 1,   TNF-α∅, 1,   VitD↑, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

BDNF↓, 1,   TrkB↓, 1,  

Protein Aggregation(tgid=19) ⓘ

AGEs↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

2/16-OHE1↓, 1,   2/16-OHE1↑, 1,   2/16-OHE1↝, 1,   ADRB2↓, 1,   AR↓, 3,   AR↝, 1,   DHT↓, 1,   ENL↑, 1,   EstroRS/ERS↑, 1,   PPARγ↓, 1,   SHBG↑, 1,   testos↓, 1,   testos∅, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↓, 2,   BioAv↑, 10,   BioAv↝, 10,   BioEnh↑, 1,   ChemoSen↑, 8,   ChemoSen∅, 1,   CYP1A2↑, 1,   CYP3A4⇅, 1,   Dose?, 13,   Dose↓, 3,   Dose↑, 7,   Dose↝, 152,   Dose∅, 4,   eff↓, 3,   eff↑, 40,   eff↝, 8,   eff∅, 12,   Half-Life↑, 1,   Half-Life↝, 6,   P-gp/ABCB1↓, 2,   RadioS↑, 5,   selectivity↑, 5,   Synergy?, 1,   Synergy↑, 10,   Synergy∅, 1,   TET2↑, 1,  

Clinical Biomarkers(tgid=22) ⓘ

ALAT↓, 1,   ALB∅, 1,   AR↓, 3,   AR↝, 1,   AST↓, 1,   BG↓, 1,   Bil∅, 1,   BUN↓, 1,   CA125↓, 1,   CA125∅, 1,   CA19-9↓, 1,   CEC↝, 1,   CIT↓, 1,   creat↓, 1,   CRP↓, 3,   CRP∅, 1,   CTC↓, 1,   EGFR↓, 3,   EstroRS/ERS↑, 1,   HemoG↑, 1,   IL6↓, 4,   Myc↓, 1,   Mye↓, 1,   NLR↓, 1,   PC↑, 3,   Polyps↓, 1,   PSA↓, 16,   PSADT↓, 1,   PSADT↑, 3,   RBC↑, 4,   UFR↑, 1,   Verbal↑, 2,   VitD↑, 1,   WBC↑, 2,  

Functional Outcomes(tgid=23) ⓘ

AEs∅, 1,   AntiCan↓, 1,   AntiCan↑, 6,   antiD↑, 4,   antiNeop↑, 2,   AntiTum↑, 4,   AntiTum∅, 1,   ANXi↓, 4,   APG↓, 2,   cachexia↓, 1,   cardioP↑, 4,   CardioT↑, 1,   CardioT↝, 1,   chemoP↑, 8,   chemoP∅, 1,   chemoPv↑, 5,   ChemoSideEff↓, 2,   cognitive↑, 1,   cognitive∅, 1,   CR↑, 5,   DCR↑, 5,   DCR↝, 1,   fatigue↓, 5,   fatigue∅, 1,   hepatoP↓, 1,   hepatoP↑, 2,   LC↑, 1,   mal↓, 1,   memory↑, 2,   Mood↑, 1,   Mucositis↓, 5,   Nausea↓, 4,   Nausea∅, 2,   neuroP↑, 1,   NP/CIPN↓, 2,   NP/CIPN↑, 3,   Obesity↓, 1,   ORR↑, 4,   ORR∅, 1,   OS?, 1,   OS↑, 55,   OS↝, 1,   OS∅, 11,   Pain↓, 9,   PFS?, 1,   PFS↑, 9,   PFS∅, 1,   QoL↑, 21,   QoL↝, 1,   QoL∅, 4,   radioP?, 1,   radioP↑, 5,   radioP↝, 1,   Remission↑, 3,   RFS↑, 1,   Risk↓, 14,   Risk↑, 2,   Risk↝, 2,   Risk∅, 6,   stomatitis↓, 1,   Strength↑, 1,   Strength∅, 1,   Stress↓, 1,   toxicity↓, 29,   toxicity↑, 1,   toxicity↝, 26,   toxicity∅, 1,   TTP↑, 1,   TumVol↓, 4,   TumW↓, 1,   Vomit↓, 4,   Vomit∅, 2,   Weight↑, 6,   Weight∅, 2,   Wound Healing↑, 1,  

Infection & Microbiome(tgid=24) ⓘ

Diar↓, 1,   Diar⇅, 1,   GutMicro↑, 3,   Inf↓, 4,   Sepsis↓, 1,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr↑, 1,   Ingr↝, 4,  
Total Targets: 317

Pathway results for Effect on Normal Cells:


NA, unassigned(tgid=0) ⓘ

NA↓, 1,   NA↑, 1,   NA↝, 1,  

Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↓, 2,   antiOx↑, 12,   Bil↓, 2,   Bil∅, 1,   Catalase↑, 1,   GPx↑, 1,   GSH↑, 5,   HDL↓, 2,   HDL↑, 4,   HO-1↑, 1,   Iron↓, 1,   Iron↑, 1,   lipid-P↓, 2,   MDA↓, 4,   MDA↑, 1,   MPOD↑, 2,   NRF2↑, 2,   PCO↓, 1,   ROS↓, 17,   SAM-e↓, 1,   SOD↑, 3,   TAC↑, 6,   TBARS↓, 1,   uricA↓, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

IronCh↑, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

Insulin↓, 1,   mitResp↑, 1,   mtDam↓, 1,   PGC-1α↑, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

12-HETE↓, 1,   5-HETE↓, 1,   ACLY↓, 1,   AcOH↑, 2,   adiP↑, 1,   ALAT↓, 6,   ALAT↑, 1,   ALAT∅, 2,   AMPK↑, 1,   Buty↑, 4,   CRM↑, 1,   DHA↑, 2,   Eic↓, 1,   FFA/NEFA↓, 1,   FFA/NEFA↝, 1,   glucose↓, 1,   glucose∅, 1,   KeyT↝, 1,   lactateProd↓, 1,   LDL↓, 11,   lipidLev↓, 1,   NH3↓, 1,   PA↑, 2,   SCFAs↑, 3,   SCFAs∅, 1,   SIRT1↑, 1,   Uridine↑, 1,  

Cell Death(tgid=5) ⓘ

BAX↓, 1,   Casp3↓, 1,   p38↓, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

CK2↓, 1,   PI3K↓, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

AntiThr↑, 3,   DNMT3A↑, 1,   HDAC3↓, 1,   other?, 3,   other↓, 4,   other↑, 18,   other↝, 20,   other∅, 1,  

DNA Damage & Repair(tgid=10) ⓘ

DNAdam↓, 1,   DNArepair↑, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

Choline↑, 1,   Diff↝, 1,   EP2↑, 1,   IGF-1↓, 1,   IGF-1↑, 1,   IGFBP3↓, 1,   NOTCH↓, 1,   Wnt↓, 1,  

Migration(tgid=13) ⓘ

AntiAg↑, 5,   AntiAg∅, 1,   MMP9↓, 1,   TGF-β↑, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

NO↓, 1,   TXA2↓, 1,   VCAM-1↓, 1,   VEGF↑, 1,  

Barriers & Transport(tgid=15) ⓘ

BBB↑, 1,   IBI↑, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CD14↑, 1,   COX1↓, 1,   Eos↓, 1,   IFN-γ↓, 1,   IFN-γ↑, 5,   IgA↑, 1,   IgE↓, 1,   IL1↓, 1,   IL10↓, 2,   IL10↑, 1,   IL10∅, 1,   IL12↓, 1,   IL17∅, 1,   IL1β↓, 6,   IL4↑, 1,   IL4∅, 1,   IL6↓, 12,   IL8↓, 1,   Imm↑, 7,   Inflam↓, 26,   IP-10/CXCL-10↓, 1,   MCP1/CCL2↓, 1,   MCP1/CCL2↝, 1,   MIP‑1α/CCL3?, 1,   NF-kB↓, 1,   NK cell↑, 5,   PGE2↓, 2,   PGE2∅, 1,   PSA↓, 1,   TNF-α↓, 9,   TNF-α↑, 3,   VitD↑, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

5-AR↓, 1,   5HT↑, 3,   Ach↑, 2,   AChE↓, 5,   BDNF↑, 8,   BDNF∅, 1,   proBDNF↑, 1,   BrainVol↑, 1,   BrainVol↝, 1,   BrainVol∅, 3,   GABA↑, 1,   NGF↑, 2,  

Protein Aggregation(tgid=19) ⓘ

APOE4↑, 1,   Aβ↓, 10,   Aβ∅, 1,   BACE/β-secretase↓, 1,   tau↓, 3,   p‑tau↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

2/16-OHE1↑, 1,   cortisol↓, 1,   END↑, 1,   ENL↑, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↓, 5,   BioAv↑, 22,   BioAv↝, 14,   Dose?, 20,   Dose↓, 1,   Dose↑, 8,   Dose↝, 143,   eff↓, 2,   eff↑, 20,   eff↝, 8,   eff∅, 1,   Half-Life↓, 2,   Half-Life↑, 2,   Half-Life↝, 20,   P450↓, 1,   Synergy↑, 6,  

Clinical Biomarkers(tgid=22) ⓘ

ADC↓, 1,   ALAT↓, 6,   ALAT↑, 1,   ALAT∅, 2,   ALB↑, 3,   ALP↓, 1,   AST↓, 4,   AST↑, 1,   AST∅, 2,   Bil↓, 2,   Bil∅, 1,   BloodF↑, 4,   BMD↑, 1,   BP↓, 12,   BP∅, 2,   Calcium↑, 1,   CCr / CrCl↓, 1,   CCr / CrCl∅, 1,   creat∅, 1,   CRP↓, 5,   FEV1↑, 2,   Hcy/homoC↓, 13,   Hcy/homoC↝, 1,   HemoG↑, 2,   HRV↑, 1,   hs-CRP↓, 2,   IL6↓, 12,   IRes↓, 1,   KeyT↝, 1,   LDH↓, 3,   NLR↓, 1,   PC∅, 1,   PEF↑, 1,   PSA↓, 1,   rHR↓, 1,   TC↓, 3,   TG/TAG↓, 3,   TMAO∅, 1,   UFR?, 1,   UFR↑, 1,   UR↓, 1,   Verbal↑, 2,   VitD↑, 1,   WBC∅, 1,  

Functional Outcomes(tgid=23) ⓘ

AntiAge↑, 1,   antiAll↑, 2,   AntiCan↑, 2,   antiD↑, 3,   AntiDiabetic↑, 2,   AntiTum↑, 3,   ANXi↓, 5,   BDI↓, 1,   BowelM↑, 1,   cardioP↑, 6,   chemoP↑, 3,   cognitive?, 1,   cognitive↓, 1,   cognitive↑, 78,   cognitive↝, 2,   cognitive∅, 12,   fatigue↓, 2,   GFR↓, 1,   GFR∅, 1,   hepatoP↑, 8,   IPSS↓, 1,   IPSS↝, 1,   Learn↑, 1,   memory↑, 26,   memory∅, 1,   Mood↑, 10,   motorD↑, 13,   MusCon↓, 1,   neuroP↑, 13,   NMSS↓, 1,   Obesity↓, 3,   OS↑, 1,   Pain↓, 12,   QoL?, 1,   QoL↑, 13,   RenoP↑, 3,   Risk↓, 6,   Risk↑, 2,   Risk↝, 1,   RT↓, 2,   Sleep↑, 12,   Strength↑, 4,   Stress↓, 6,   Tinn↓, 1,   toxicity↓, 40,   toxicity↑, 1,   toxicity↝, 4,   toxicity∅, 7,   UPDRS↓, 1,   UPDRSIII∅, 1,   Weight↓, 1,   Wound Healing↑, 1,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↑, 2,   AntiFungal↑, 2,   AntiViral↑, 4,   Bacteria↓, 2,   GutMicro↑, 10,   GutMicro∅, 1,   Inf↓, 1,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr↝, 8,  
Total Targets: 266

Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:%  State#:%  Dir#:%
wNotes=0 sortOrder:rid,rpid

 

Home Page